Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
Recruiting now
Conditions studied: COPD, ILD, Bronchiectasis, Pneumothorax, Pneumonia, Pleural Effusion Disorder, Pulmonary Oedema
In brief
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Key facts
- Study ID
- NCT06983366
- Run by
- Assiut University
- People needed
- 700
- Starts
- 2025-05-30
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18 years and older.
- Diagnosed with one of the specified pulmonary diseases, or a healthy control
- Able to provide written informed consent
You may not qualify if…
- Inability to tolerate or undergo a lung ultrasound
- Extensive chest wall pathology precluding assessment
- Unscorable >2 zones per protocol
- Withdrawal of consent
- Mechanically-ventilated patients
Where it is running
- Assiut University- Faculty of Medicine — Asyut, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.